PHI with acute yellow liver atrophy
How does this condition affect your private health insurance?
Acute yellow liver atrophy, clinically known as acute hepatic necrosis or acute liver failure, is a rare, severe syndrome characterized by rapid, massive destruction of liver cells. This leads to sudden onset of severe liver dysfunction in individuals without pre-existing chronic liver disease. Key features include jaundice, coagulopathy, and hepatic encephalopathy, often progressing swiftly to multi-organ failure. Etiologies commonly involve viral infections (e.g., hepatitis A, B, E), drug-induced liver injury (e.g., acetaminophen overdose), or autoimmune hepatitis. The extensive cellular necrosis results in a shrunken, yellow-colored liver. Prognosis is frequently poor without prompt, aggressive medical intervention, including potential liver transplantation.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to 2-3 weeks (acute, rapid progression)
Duration of Illness (Lifetime)
Acute, life-threatening; if survived, often a one-time event with potential long-term sequelae or requiring a liver transplant.
Cost of Treatment (Initial)
Very high, ranging from tens of thousands to hundreds of thousands of dollars, especially if a liver transplant is required.
Cost of Treatment (Lifetime)
Variable; if complete recovery, moderate follow-up costs. If liver transplant, very high lifelong costs for immunosuppression and monitoring.
Mortality Rate
High, up to 50-80% without liver transplantation in severe cases.
Risk of Secondary Damages
High, including hepatic encephalopathy, acute kidney injury, sepsis, and gastrointestinal bleeding.
Probability of Full Recovery
Moderate, especially if the underlying cause is treatable and detected early; significantly improved with successful liver transplantation.
Underlying Disease Risk
High, as it is often a manifestation of severe viral hepatitis (e.g., Hepatitis B), drug-induced liver injury (e.g., acetaminophen overdose), or autoimmune hepatitis.